Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-in-human randomized placebo-controlled study of oral GSK2556286 in healthy adults
NL-OMON55164Phase 1Active, not recruiting
- Sponsor
- GSK
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Tuberculosis (TB) comparing GSK2556286 with Placebo (2 arms). Primary endpoints: Safety and tolerability, Plasma concentrations and derived pharmacokinetics and 2 more. Started Nov 2020; status: active, not recruiting.
02
Drugs
GSK2556286
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NL-OMON55164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55164.